$ACR
ACRES Commercial Realty Corp.

2020 Q1 Form 10-Q Financial Statement

#000156459020024285 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $14.92M $14.56M
YoY Change 2.44% 26.88%
Cost Of Revenue $20.51M $21.48M
YoY Change -4.52% 24.88%
Gross Profit -$172.6M $12.48M
YoY Change -1482.69% 55.61%
Gross Profit Margin -1156.65% 85.7%
Selling, General & Admin $3.500M $3.000M
YoY Change 16.67% -21.67%
% of Gross Profit 24.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $700.0K $400.0K
YoY Change 75.0% -56.33%
% of Gross Profit 3.21%
Operating Expenses $20.05M $4.310M
YoY Change 365.2% -28.81%
Operating Profit -$192.6M $8.170M
YoY Change -2457.53% 315.56%
Interest Expense $18.39M $19.40M
YoY Change -5.16% 34.84%
% of Operating Profit 237.39%
Other Income/Expense, Net -$189.3M -$1.000K
YoY Change 18927800.0% -99.98%
Pretax Income -$196.5M $8.170M
YoY Change -2505.39% -4905.88%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$196.5M $8.133M
YoY Change -2516.34% 7293.64%
Net Earnings / Revenue -1317.25% 55.85%
Basic Earnings Per Share -$18.89 $0.53
Diluted Earnings Per Share -$18.89 $0.53
COMMON SHARES
Basic Shares Outstanding 10.54M 31.38M
Diluted Shares Outstanding 10.54M 31.53M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.80M $55.70M
YoY Change -23.16% -9.43%
Cash & Equivalents $42.75M $55.66M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.10M $64.20M
YoY Change -21.96% -6.28%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $78.80M $442.4M
YoY Change -82.19% 71.94%
Other Assets $78.80M $25.10M
YoY Change 213.94% -67.9%
Total Long-Term Assets $2.039B $2.133B
YoY Change -4.42% 23.93%
TOTAL ASSETS
Total Short-Term Assets $50.10M $64.20M
Total Long-Term Assets $2.039B $2.133B
Total Assets $2.089B $2.197B
YoY Change -4.93% 22.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.300M $4.400M
YoY Change -2.27% -34.33%
Accrued Expenses $2.300M $2.200M
YoY Change 4.55% -31.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.100M $15.40M
YoY Change -40.91% 6.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.725B $1.620B
YoY Change 6.45% 32.56%
Other Long-Term Liabilities $13.10M $3.800M
YoY Change 244.74% 31.03%
Total Long-Term Liabilities $1.738B $1.624B
YoY Change 7.01% 32.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.100M $15.40M
Total Long-Term Liabilities $1.738B $1.624B
Total Liabilities $1.747B $1.640B
YoY Change 6.55% 32.27%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.086B $1.083B
YoY Change 0.2% 0.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $342.1M $557.8M
YoY Change
Total Liabilities & Shareholders Equity $2.089B $2.197B
YoY Change -4.93% 22.78%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$196.5M $8.133M
YoY Change -2516.34% 7293.64%
Depreciation, Depletion And Amortization $700.0K $400.0K
YoY Change 75.0% -56.33%
Cash From Operating Activities $2.338M $3.995M
YoY Change -41.48% -65.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$62.70M -$91.90M
YoY Change -31.77% 153.17%
Cash From Investing Activities -$62.73M -$91.91M
YoY Change -31.75% 153.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 74.07M 55.59M
YoY Change 33.24% -147.24%
NET CHANGE
Cash From Operating Activities 2.338M 3.995M
Cash From Investing Activities -62.73M -91.91M
Cash From Financing Activities 74.07M 55.59M
Net Change In Cash 13.67M -32.33M
YoY Change -142.28% -77.28%
FREE CASH FLOW
Cash From Operating Activities $2.338M $3.995M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductAndServiceOtherMember
CY2019Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductAndServiceOtherMember
CY2020Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
CY2019Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
CY2020Q1 xan Loans Pledged As Collateral Gross
LoansPledgedAsCollateralGross
1892486000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
20641000
CY2020Q1 us-gaap Other Assets
OtherAssets
9603000
CY2020Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
13466000
CY2020Q1 us-gaap Assets
Assets
2089118000
CY2020Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
4348000
CY2020Q1 us-gaap Management Fee Payable
ManagementFeePayable
692000
CY2020Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2270000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-196521000
CY2019Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1025000
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
747000
CY2020Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
16149000
CY2020Q1 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-185357000
CY2019Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
446000
CY2020Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1724932000
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
1725000
CY2019Q1 xan Interest And Fee Income Loans Held In Portfolio
InterestAndFeeIncomeLoansHeldInPortfolio
27343000
CY2019Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
6375000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
33290000
CY2020Q1 us-gaap Interest Expense
InterestExpense
18394000
CY2019Q1 us-gaap Interest Expense
InterestExpense
19395000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14896000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14537000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26000
CY2020Q1 us-gaap Revenues
Revenues
14919000
CY2019Q1 us-gaap Revenues
Revenues
14563000
CY2020Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
11326000
CY2020Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
33000
CY2020Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
1735000
CY2020Q1 us-gaap Liabilities
Liabilities
1747061000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32042061
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32042061
CY2020Q1 xan Common Stock Restricted Shares
CommonStockRestrictedShares
351325
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
32000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1085539000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10877000
CY2020Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
732642000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
342057000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2089118000
CY2020Q1 xan Interest And Fee Income Loans Held In Portfolio
InterestAndFeeIncomeLoansHeldInPortfolio
27041000
CY2020Q1 xan Management Fees Related Party
ManagementFeesRelatedParty
2117000
CY2019Q1 xan Management Fees Related Party
ManagementFeesRelatedParty
2083000
CY2020Q1 xan Equity Compensation Related Party
EquityCompensationRelatedParty
498000
CY2019Q1 xan Equity Compensation Related Party
EquityCompensationRelatedParty
683000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3382000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2577000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
24000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
16149000
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1025000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
22161000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
6392000
CY2020Q1 xan Revenues Less Operating Expense
RevenuesLessOperatingExpense
-7242000
CY2019Q1 xan Revenues Less Operating Expense
RevenuesLessOperatingExpense
8171000
CY2020Q1 us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
-185357000
CY2020Q1 xan Fair Value Adjustments On Financial Assets Held For Sale
FairValueAdjustmentsOnFinancialAssetsHeldForSale
3791000
CY2019Q1 xan Fair Value Adjustments On Financial Assets Held For Sale
FairValueAdjustmentsOnFinancialAssetsHeldForSale
102000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-86000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
101000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-189234000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-196476000
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
8170000
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-196476000
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
8170000
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-45000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-37000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-196521000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
8133000
CY2020Q1 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2588000
CY2019Q1 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2588000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-199109000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5545000
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-6.30
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.18
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.30
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-6.30
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.18
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.30
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31626204
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31379253
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31626204
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31531286
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-196521000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
8133000
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-185357000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-191283000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5865000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
23000
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
23000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-6749000
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-1693000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12698000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4149000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-209219000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
12282000
CY2020Q1 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2588000
CY2019Q1 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2588000
CY2019Q1 xan Changes In Operating Assets And Liabilities Operating Activities
ChangesInOperatingAssetsAndLiabilitiesOperatingActivities
6287000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2380000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4139000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-211807000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9694000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
553819000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
683000
CY2019Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2588000
CY2019Q1 xan Securities Available For Sale Fair Value Adjustment Net
SecuritiesAvailableForSaleFairValueAdjustmentNet
-5865000
CY2019Q1 xan Designated Derivatives Fair Value Adjustment
DesignatedDerivativesFairValueAdjustment
-1716000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6373000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
557823000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
556398000
CY2019Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-3032000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
553366000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
498000
CY2020Q1 xan Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
2588000
CY2020Q1 xan Securities Available For Sale Without An Allowance For Credit Losses Fair Value Adjustment Net
SecuritiesAvailableForSaleWithoutAnAllowanceForCreditLossesFairValueAdjustmentNet
5926000
CY2020Q1 xan Designated Derivatives Fair Value Adjustment
DesignatedDerivativesFairValueAdjustment
-6772000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
342057000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-196521000
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-45000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-37000
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-196476000
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
8170000
CY2020Q1 xan Share Based Compensation Nonemployee And Directors
ShareBasedCompensationNonemployeeAndDirectors
498000
CY2019Q1 xan Share Based Compensation Nonemployee And Directors
ShareBasedCompensationNonemployeeAndDirectors
683000
CY2020Q1 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-3791000
CY2019Q1 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-102000
CY2020Q1 xan Changes In Operating Assets And Liabilities Operating Activities
ChangesInOperatingAssetsAndLiabilitiesOperatingActivities
7686000
CY2020Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-42000
CY2019Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-144000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2338000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3995000
CY2020Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
190318000
CY2019Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
176279000
CY2020Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
109697000
CY2019Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
99533000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
24610000
CY2019Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
27396000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
4733000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
12095000
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
37764000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-62734000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-92047000
CY2019Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
135000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62734000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91912000
CY2020Q1 xan Proceeds From Warehouse Financing Facilities And Repurchase Agreements
ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements
271872000
CY2019Q1 xan Proceeds From Warehouse Financing Facilities And Repurchase Agreements
ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements
156174000
CY2020Q1 xan Proceeds From Issuance Of Securitization Of Notes Payable
ProceedsFromIssuanceOfSecuritizationOfNotesPayable
393280000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
74065000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
55588000
CY2020Q1 xan Repayments Of Warehouse Financing Facilities And Repurchase Agreements
RepaymentsOfWarehouseFinancingFacilitiesAndRepurchaseAgreements
494474000
CY2019Q1 xan Repayments Of Warehouse Financing Facilities And Repurchase Agreements
RepaymentsOfWarehouseFinancingFacilitiesAndRepurchaseAgreements
42125000
CY2020Q1 xan Payments Of Commercial Real Estate Notes Payable
PaymentsOfCommercialRealEstateNotesPayable
58434000
CY2019Q1 xan Payments Of Commercial Real Estate Notes Payable
PaymentsOfCommercialRealEstateNotesPayable
50333000
CY2020Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
21182000
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5642000
CY2020Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2588000
CY2019Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2588000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8767000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5540000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74065000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55588000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13669000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32329000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94434000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95474000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108103000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63145000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
20842000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
19636000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and within the period of financial results. Actual results could differ from those estimates. Estimates affecting the accompanying consolidated financial statements include but are not limited to the net realizable and fair values of the Company’s investments and derivatives, the estimated life used on investments to calculate amortization and accretion of premiums and discounts, respectively, provisions for credit losses and the disclosure of contingent liabilities.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, a novel strain of coronavirus (“COVID-19”) was identified. The resulting global proliferation of the virus led the World Health Organization to designate COVID-19 as a pandemic and numerous countries, including the United States, to declare national emergencies. Many countries have responded to the outbreak by instituting quarantines and restrictions on travel, which have resulted in the closure or remote operation of non-essential businesses. Such actions have produced material and previously unforeseeable shocks to global markets, disruptions to global supply chains and adversity to many industries and economies as whole. The rapid development of the pandemic and the resulting economic effects have created uncertainty surrounding the ultimate impact on the global economy generally, and the commercial real estate business in particular, that make estimates and assumptions as of March 31, 2020 inherently less certain than they would be absent the current and potential impacts of COVID-19. As a result, actual losses could differ from estimated amounts. The Company believes the estimates and assumptions underlying the consolidated financial statements are reasonable and supportable based on the information available at March 31, 2020. Actual results may ultimately differ from those estimates.</p>
CY2020Q1 xan Cash Balance In Excess Of Federal Deposit Insurance Limit Amount
CashBalanceInExcessOfFederalDepositInsuranceLimitAmount
40100000
CY2019Q4 xan Cash Balance In Excess Of Federal Deposit Insurance Limit Amount
CashBalanceInExcessOfFederalDepositInsuranceLimitAmount
77600000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42752000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55660000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
65351000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7485000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108103000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63145000
CY2019Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
32900000
CY2020Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
32900000
CY2020Q1 xan Operating Loss Carryforwards Valuation Allowance Tax Expense Impact
OperatingLossCarryforwardsValuationAllowanceTaxExpenseImpact
9900000
CY2019Q4 xan Operating Loss Carryforwards Valuation Allowance Tax Expense Impact
OperatingLossCarryforwardsValuationAllowanceTaxExpenseImpact
9900000
CY2020Q1 xan Current Expected Credit Losses Reserve
CurrentExpectedCreditLossesReserve
4500000
CY2020Q1 xan Current Expected Credit Losses Reserve Recorded As Charge To Retained Earnings
CurrentExpectedCreditLossesReserveRecordedAsChargeToRetainedEarnings
3000000.0
CY2020Q1 xan Current Expected Credit Losses Reserve Per Share Recorded As Charge To Retained Earnings
CurrentExpectedCreditLossesReservePerShareRecordedAsChargeToRetainedEarnings
0.10
CY2020Q1 xan Percentage Of Estimated Current Expected Credit Losses Reserve Out Of Aggregate Outstanding Principal Balance Of Commercial Loan Portfolio
PercentageOfEstimatedCurrentExpectedCreditLossesReserveOutOfAggregateOutstandingPrincipalBalanceOfCommercialLoanPortfolio
0.0025
CY2020Q1 xan Percentage Of Credit Losses Reserve Out Of Aggregate Outstanding Principal Balance Of Commercial Loan Portfolio
PercentageOfCreditLossesReserveOutOfAggregateOutstandingPrincipalBalanceOfCommercialLoanPortfolio
0.0109
CY2020Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
0
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
19500000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
11511000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1880975000
CY2020Q1 xan Financing Receivable Recorded Investment Past Due And Current
FinancingReceivableRecordedInvestmentPastDueAndCurrent
1892486000
CY2020Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
11511000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
11503000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1779942000
CY2019Q4 xan Financing Receivable Recorded Investment Past Due And Current
FinancingReceivableRecordedInvestmentPastDueAndCurrent
1791445000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
11503000
CY2020Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
77350000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
106000
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
77244000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
514894000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7591000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1771000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
520714000
CY2019Q4 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
466900000
CY2020Q1 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
74100000
CY2020Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1747028000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
22096000
CY2020Q1 us-gaap Notes Payable
NotesPayable
1724932000
CY2020Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0260
CY2020Q1 xan Debt Instrument Maturity Date Free Form
DebtInstrumentMaturityDateFreeForm
P10Y7M6D
CY2020Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
2003362000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1891796000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19219000
CY2019Q4 us-gaap Notes Payable
NotesPayable
1872577000
CY2019Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0345
CY2019 xan Debt Instrument Maturity Date Free Form
DebtInstrumentMaturityDateFreeForm
P7Y4M24D
CY2019Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
2170546000
CY2020Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
451969000
CY2020Q1 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
558238000
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
919805000
CY2019Q4 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
1189619000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
1747028000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
321755000
CY2020Q1 xan Longterm Debt Maturing In Year Two
LongtermDebtMaturingInYearTwo
132332000
CY2020Q1 xan Longterm Debt Maturing In Year Three
LongtermDebtMaturingInYearThree
143750000
CY2020Q1 xan Longterm Debt Maturing In Year Four
LongtermDebtMaturingInYearFour
0
CY2020Q1 xan Longterm Debt Maturing In Year Five And After
LongtermDebtMaturingInYearFiveAndAfter
1149191000
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-6.30
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
498000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
683000
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-196476000
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
8170000
CY2020Q1 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2588000
CY2019Q1 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2588000
CY2020Q1 xan Net Income Loss From Continuing Operations Allocable To Common Shares
NetIncomeLossFromContinuingOperationsAllocableToCommonShares
-199064000
CY2019Q1 xan Net Income Loss From Continuing Operations Allocable To Common Shares
NetIncomeLossFromContinuingOperationsAllocableToCommonShares
5582000
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-45000
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-37000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-199109000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5545000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31626204
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31379253
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
152033
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31626204
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31531286
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.18
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.30
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-6.30
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.18
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.30
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2020Q1 xan Reit Required Taxable Income Distribution Percentage
REITRequiredTaxableIncomeDistributionPercentage
0.90
CY2020Q1 xan Reit Taxable Income Distribution For Exempt Federal Income Taxes Percentage
REITTaxableIncomeDistributionForExemptFederalIncomeTaxesPercentage
1
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
30000
CY2019Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
30000
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
0
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0
CY2019Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
30000
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
0
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
11326000
CY2020Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
11326000
CY2020Q1 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
0
CY2020Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
11326000
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
0
CY2020Q1 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
451969000
CY2020Q1 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0
CY2020Q1 xan Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral
451969000
CY2020Q1 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
402377000
CY2020Q1 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
49592000
CY2020Q1 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2020Q1 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross
463295000
CY2020Q1 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset
0
CY2020Q1 xan Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Not Offset Against Collateral
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountNotOffsetAgainstCollateral
463295000
CY2020Q1 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities
402377000
CY2020Q1 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash
60918000
CY2020Q1 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4558000
CY2019Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
4558000
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
0
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
4558000
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
0
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
919805000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0
CY2019Q4 xan Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral
919805000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
915041000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
4764000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross
924363000
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset
0
CY2019Q4 xan Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Not Offset Against Collateral
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountNotOffsetAgainstCollateral
924363000
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities
915041000
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash
9322000
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2020Q1 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
558200000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
1200000000
CY2020Q1 us-gaap Litigation Reserve
LitigationReserve
0
CY2019Q4 us-gaap Litigation Reserve
LitigationReserve
0

Files In Submission

Name View Source Status
0001564590-20-024285-index-headers.html Edgar Link pending
0001564590-20-024285-index.html Edgar Link pending
0001564590-20-024285.txt Edgar Link pending
0001564590-20-024285-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gegifq30meb5000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xan-10q_20200331.htm Edgar Link pending
xan-10q_20200331_htm.xml Edgar Link completed
xan-20200331.xsd Edgar Link pending
xan-20200331_cal.xml Edgar Link unprocessable
xan-20200331_def.xml Edgar Link unprocessable
xan-20200331_lab.xml Edgar Link unprocessable
xan-20200331_pre.xml Edgar Link unprocessable
xan-ex311_10.htm Edgar Link pending
xan-ex312_9.htm Edgar Link pending
xan-ex321_8.htm Edgar Link pending
xan-ex322_6.htm Edgar Link pending
xan-ex993_83.htm Edgar Link pending
xan-ex994_82.htm Edgar Link pending